NICE

Patients

Hand flips a block changing 2021 to 2022. New year beginning. Holidays and Christmas. Trends and changes in the World. Summing work done. Build plans. New normal. Keep up with everything planned.

2021 in review: Building the framework of a patient-centric ...

Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action.

News

Samantha Roberts to replace Gillian Leng as CEO of NICE

Prof Gillian Leng's replacement as chief executive of the National Institute for Health and Care Excellence (NICE) has been named as Dr Samantha Roberts, currently managing director for hea

News

NICE gives Keytruda parity with Opdivo for adjuvant melanoma

After three years of availability via the Cancer Drugs Fund (CDF), MSD's checkpoint inhibitor Keytruda has now been approved for routine NHS use after surgery for people with melanoma to pr

News

After Scotland says no, NICE backs Lilly's Retsevmo for lung...

Eli Lilly's RET inhibitor Retsevmo can now be prescribed on the NHS for people with RET fusion-positive advanced non-small cell lung cancer (NSCLC) in England and Wales, within the Cancer D

Patients

UK-wide whole genome sequencing for newborns is feasible - b...

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year ann

News

Young lonely man in a wheelchair on a balcony looking at the nature in the spring

NICE reaches a deal with Roche on access to oral SMA drug Ev...

Roche's oral treatment Evrysdi for the rare genetic disease spinal muscular atrophy (SMA) will be made available on the NHS in England, after NICE reached a three-year access agreement with

2021 in review: Building the framework of a patient-centric ...

Samantha Roberts to replace Gillian Leng as CEO of NICE

NICE gives Keytruda parity with Opdivo for adjuvant melanoma

After Scotland says no, NICE backs Lilly's Retsevmo for lung...

UK-wide whole genome sequencing for newborns is feasible - b...

NICE reaches a deal with Roche on access to oral SMA drug Ev...

FDA starts review of Regeneron's drug for rare disease FOP

How to meet your physicians where they are online

NICE

Editor's Picks